We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Adds Another Site to Ranbaxy’s Consent Decree, Issues Import Alert
FDA Adds Another Site to Ranbaxy’s Consent Decree, Issues Import Alert
September 24, 2013
In an enforcement action industry experts say signals the FDA’s doubts about Ranbaxy’s culture of quality, the agency Sept. 16 added the generic giant’s Mohali, India, facility to a January 2012 consent decree and issued an import alert on the plant, which manufactures oral solids.